Tumour necrosis factor-alpha gene -238G/A promoter polymorphism associated with a more rapid onset of lipodystrophy
Authors:
- Corey MooreCMCorey Moore
- Alison CastleyACAlison Castley
- David SayerDSDavid Sayer
- Cyril MamotteCMCyril Mamotte
- Mina JohnMJMina John
- Ian JamesIJIan James
- Simon MallalSMSimon Mallal
- 1 January 2003
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (1) , 121-123
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistanceThe Lancet, 2002
- Synergistic Antiadipogenic Effects of HIV Type 1 Protease Inhibitors with Tumor Necrosis Factor α : Suppression of Extracellular Insulin Action Mediated by Extracellular Matrix-Degrading ProteasesAIDS Research and Human Retroviruses, 2001
- Influence of TNFα gene polymorphisms on TNFα production and diseaseHuman Immunology, 2001
- TNFα Induces and Insulin Inhibits Caspase 3-Dependent Adipocyte ApoptosisBiochemical and Biophysical Research Communications, 2001
- Antiretroviral Therapy and the Lipodystrophy SyndromeAntiviral Therapy, 2001
- Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infectionAIDS, 2000
- The role of TNFα in adipocyte metabolismSeminars in Cell & Developmental Biology, 1999